Dash Bio

Dash Bio operates a cutting-edge, automated platform designed to revolutionize clinical bioanalysis by delivering high-quality results at unprecedented speeds. The company serves pharmaceutical and biotechnology firms, providing essential bioanalytical services from assay development and validation to sample analysis. Operating in the clinical research market, Dash Bio leverages its GLP-compliant laboratory to offer a core suite of assays that support in vivo and clinical studies. The business model focuses on providing rapid and reliable bioanalysis, which is crucial for drug development and regulatory submissions. Revenue is generated through service contracts with clients who require efficient and accurate bioanalytical data to advance their research and development projects. Dash Bio's commitment to innovation and quality positions it as a leader in the bioanalysis sector, driven by a team of inspired and curious professionals dedicated to transformative work.

Keywords: automated platform, clinical bioanalysis, pharmaceutical, biotechnology, GLP-compliant, assay development, sample analysis, drug development, innovation, quality.